Refined structures of mouse P-glycoprotein

Protein Science

Volumn 23, Issue 1, 2014, Pages 34-46

  Li, Jingzhi ^a   Jaimes, Kimberly F ^a   Aller, Stephen G ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

Multidrug resistance; P glycoprotein; Protein modeling; SAD phasing; X ray crystallography

Indexed keywords

AMINO ACID; MERCURY; MULTIDRUG RESISTANCE PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CHEMICAL LABELING; CONTROLLED STUDY; DRUG BINDING; FOURIER ANALYSIS; HUMAN VERSUS ANIMAL COMPARISON; MOLECULAR MODEL; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN MOTIF; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY; STRUCTURE ANALYSIS; SUBURETHRAL SLING;

MULTIDRUG RESISTANCE; P-GLYCOPROTEIN; PROTEIN MODELING; SAD PHASING; X-RAY CRYSTALLOGRAPHY;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; AMINO ACIDS, AROMATIC; ANIMALS; BIOLOGICAL TRANSPORT; CRYSTALLOGRAPHY, X-RAY; FOURIER ANALYSIS; HUMANS; MICE; MODELS, MOLECULAR; P-GLYCOPROTEIN; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 84900449189     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1002/pro.2387     Document Type: Article

References (53)

1. Aller SG, Yu J, Ward A, Weng Y, Chittaboina S, Zhuo R, Harrell PM, Trinh YT, Zhang Q, Urbatsch IL, Chang G (2009) Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science 323:1718-1722
2. Chen Y, Pant AC, Simon SM (2001) P-glycoprotein does not reduce substrate concentration from the extracellular leaflet of the plasma membrane in living cells. Cancer Res 61:7763-7769
3. Shapiro AB, Ling V (1998) Transport of LDS-751 from the cytoplasmic leaflet of the plasma membrane by the rhodamine-123-selective site of P-glycoprotein. Eur J Biochem 254:181-188
4. Shapiro AB, Ling V (1997) Extraction of Hoechst 33342 from the cytoplasmic leaflet of the plasma membrane by P-glycoprotein. Eur J Biochem 250:122-129
5. Romsicki Y, Sharom FJ (2001) Phospholipid flippase activity of the reconstituted P-glycoprotein multidrug transporter. Biochemistry 40:6937-6947
6. Loo TW, Bartlett MC, Clarke DM (2010) Human Pglycoprotein is active when the two halves are clamped together in the closed conformation. Biochem Biophys Res Commun 395:436-440
7. Gottesman MM, Ambudkar SV, Xia D (2009) Structure of a multidrug transporter. Nat Biotechnol 27:546-547
8. Wen PC, Verhalen B, Wilkens S, McHaourab H, Tajkhorshid E (2013) On the origin of large flexibility of P-glycoprotein in the inward-facing state. J Biol Chem 288:19211-19220
9. Wise JG (2012) Catalytic transitions in the human MDR1 P-glycoprotein drug binding sites. Biochemistry 51:5125-5141
10. Dauter Z, Dauter M, Dodson E (2002) Jolly SAD. Acta Cryst D 58:494-506
11. Read RJ, McCoy AJ (2011) Using SAD data in Phaser. Acta Cryst D 67:338-344
12. Dawson RJP, Locher KP (2006) Structure of a bacterial multidrug ABC transporter. Nature 443:180-185
13. Ogino J, Moore RE, Patterson GM, Smith CD (1996) Dendroamides, new cyclic hexapeptides from a bluegreen alga. Multidrug-resistance reversing activity of dendroamide A. J Nat Prod 59:581-586
14. Jin MS, Oldham ML, Zhang Q, Chen J (2012) Crystal structure of the multidrug transporter P-glycoprotein from Caenorhabditis elegans. Nature 490:566-569
15. Loo TW, Bartlett MC, Clarke DM (2009) Identification of residues in the drug translocation pathway of the human multidrug resistance P-glycoprotein by arginine mutagenesis. J Biol Chem 284:24074-24087
16. Loo TW, Bartlett MC, Clarke DM (2006) Transmembrane segment 1 of human P-glycoprotein contributes to the drug-binding pocket. Biochem J 396:537-545
17. Loo TW, Bartlett MC, Clarke DM (2006) Transmembrane segment 7 of human P-glycoprotein forms part of the drug-binding pocket. Biochem J 399:351-359
18. Loo TW, Bartlett MC, Clarke DM (2007) Suppressor mutations in the transmembrane segments of Pglycoprotein promote maturation of processing mutants and disrupt a subset of drug-binding sites. J Biol Chem 282:32043-32052
19. Loo TW, Clarke DM (2005) Do drug substrates enter the common drug-binding pocket of P-glycoprotein through gates? Biochem Biophys Res Commun 329: 419-422
20. Loo TW, Clarke DM (2013) Drug rescue distinguishes between different structural models of human Pglycoprotein. Biochemistry 52:7167-7169
21. Loo TW, Bartlett MC, Clarke DM (2004) Val133 and Cys137 in transmembrane segment 2 are close to Arg935 and Gly939 in transmembrane segment 11 of human P-glycoprotein. J Biol Chem 279:18232-18238
22. Loo TW, Bartlett MC, Clarke DM (2004) Disulfide cross-linking analysis shows that transmembrane segments 5 and 8 of human P-glycoprotein are close together on the cytoplasmic side of the membrane. J Biol Chem 279:7692-7697
23. Zolnerciks JK, Wooding C, Linton KJ (2007) Evidence for a Sav1866-like architecture for the human multidrug transporter P-glycoprotein. FASEB J 21:3937-3948
24. Loo TW, Bartlett MC, Clarke DM (2008) Processing mutations disrupt interactions between the nucleotide binding and transmembrane domains of P-glycoprotein and the cystic fibrosis transmembrane conductance regulator (CFTR). J Biol Chem 283:28190-28197.
25. Ward A, Reyes CL, Yu J, Roth CB, Chang G (2007) Flexibility in the ABC transporter MsbA: Alternating access with a twist. Proc Natl Acad Sci USA 104: 19005-19010
26. Borbat PP, Surendhran K, Bortolus M, Zou P, Freed JH, McHaourab HS (2007) Conformational motion of the ABC transporter MsbA induced by ATP hydrolysis. PLoS Biol 5:e271
27. van Veen HW, Callaghan R, Soceneantu L, Sardini A, Konings WN, Higgins CF (1998) A bacterial antibioticresistance gene that complements the human multidrug-resistance P-glycoprotein gene. Nature 391: 291-295
28. Doerrler WT, Reedy MC, Raetz CR (2001) An Escherichia coli mutant defective in lipid export. J Biol Chem 276:11461-11464
29. Zhou Z, White KA, Polissi A, Georgopoulos C, Raetz CR (1998) Function of Escherichia coli MsbA, an essential ABC family transporter, in lipid A and phospholipid biosynthesis. J Biol Chem 273:12466-12475
30. Segrest JP, Jones MK, Mishra VK, Anantharamaiah GM (2002) Experimental and computational studies of the interactions of amphipathic peptides with lipid surfaces. Curr Top Membr 52:397-435
31. Borhani DW, Rogers DP, Engler JA, Brouillette CG( 1997) Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation. Proc Natl Acad Sci USA 94:12291-12296
32. Li-Blatter X, Seelig A (2010) Exploring the Pglycoprotein binding cavity with polyoxyethylene alkyl ethers. Biophys J 99:3589-3598
33. Plevin MJ, Bryce DL, Boisbouvier J (2010) Direct detection of CH/pi interactions in proteins. Nat Chem 2:466-471
34. Toth G, Bowers SG, Truong AP, Probst G (2007) The role and significance of unconventional hydrogen bonds in small molecule recognition by biological receptors of pharmaceutical relevance. Curr Pharm Des 13:3476-3493
35. Khare D, Oldham ML, Orelle C, Davidson AL, Chen J( 2009) Alternating access in maltose transporter mediated by rigid-body rotations. Mol Cell 33:528-536
36. Mourez M, Hofnung M, Dassa E (1997) Subunit interactions in ABC transporters: A conserved sequence in hydrophobic membrane proteins of periplasmic permeases defines an important site of interaction with the ATPase subunits. EMBO J 16:3066-3077
37. Ward AB, Szewczyk P, Grimard V, Lee CW, Martinez L, Doshi R, Caya A, Villaluz M, Pardon E, Cregger C, Swartz DJ, Falson PG, Urbatsch IL, Govaerts C, Steyaert J, Chang G (2013) Structures of Pglycoprotein reveal its conformational flexibility and an epitope on the nucleotide-binding domain. Proc Natl Acad Sci USA 110:13386-13391
38. Loo TW, Clarke DM (2013) A salt bridge in intracellular loop 2 is essential for folding of human Pglycoprotein. Biochemistry 52:3194-3196
39. Loo TW, Bartlett MC, Clarke DM (2002) Introduction of the most common cystic fibrosis mutation (Delta F508) into human P-glycoprotein disrupts packing of the transmembrane segments. J Biol Chem 277:27585-27588
40. Loo TW, Bartlett MC, Clarke DM (2010) The V510D suppressor mutation stabilizes DeltaF508-CFTR at the cell surface. Biochemistry 49:6352-6357
41. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ (2007) Phaser crystallographic software. J Appl Cryst 40:658-674
42. Wang BC (1985) Resolution of phase ambiguity in macromolecular crystallography. Methods Enzymol 115:90-112
43. Chang G (2007) Retraction of Structure of MsbA from Vibrio cholera: A multidrug resistance ABC transporter homolog in a closed conformation [J Mol Biol (2003) 330 419-430]. J Mol Biol 369:596
44. Chang G, Roth CB, Reyes CL, Pornillos O, Chen YJ, Chen AP (2006) Retraction. Science 314:1875
45. Matthews BW (2007) Five retracted structure reports: Inverted or incorrect? Protein Sci 16:1013-1016
46. Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse- Kunstleve RW, McCoy AJ, Moriarty NW, Oeffner R, Read RJ, Richardson DC, Richardson JS, Terwilliger TC, Zwart PH (2010) PHENIX: A comprehensive Python-based system for macromolecular structure solution. Acta Cryst D 66:213-221
47. Terwilliger TC (2003) SOLVE and RESOLVE: Automated structure solution and density modification. Methods Enzymol 374:22-37
48. DeLano WL (2002) The PyMol Molecular Graphics System, Version 1.5.0.4 Schrodinger, LLC
49. Emsley P, Cowtan K (2004) Coot: Model-building tools for molecular graphics. Acta Cryst D 60:2126-2132
50. Painter J, Merritt EA (2006) Optimal description of a protein structure in terms of multiple groups undergoing TLS motion. Acta Cryst D 62:439-450
51. Loo TW, Clarke DM (2001) Defining the drug-binding site in the human multidrug resistance P-glycoprotein using a methanethiosulfonate analog of verapamil, MTS-verapamil. J Biol Chem 276:14972-14979
52. Loo TW, Clarke DM (1997) Identification of residues in the drug-binding site of human P-glycoprotein using a thiol-reactive substrate. J Biol Chem 272: 31945-31948
53. Loo TW, Bartlett MC, Clarke DM (2003) Methanethiosulfonate derivatives of rhodamine and verapamil activate human P-glycoprotein at different sites. J Biol Chem 278:50136-50141